Indegene Ltd
As of 20 Nov 2026, Indegene is in Stage 2, the uptrend phase, now in week 14 (since 13 Aug 2026). It closed at ₹658, 1.3% below its 52-week high and above its 200-day average, which is rising. In Industrials, 16.6% of stocks are in Stage 2.
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. More about the company
Pro read
ProINDGN is about 3 months into its Stage 2 advance, 9% above its 50-day average and at its 52-week high. With the trend established, this middle stretch has tended to be the steadiest part of a move.
Its relative strength is 83 of 99, a leader among NSE stocks over the past year. Business Support Services ranks 47 of 106 industries by the strength of its stocks.
Stocks with a similar setup at this point in their move ran 0.1 points behind the average stock over the next 30 sessions on average, after costs, and their typical best close within 60 sessions was 15% above entry.
The trend read holds while it stays in Stage 2. A close below ₹604, its 50-day average, would put it at rest; ₹533, 20% under its 52-week high of ₹666, is where a trailing stop would sit.
Setup-score rank among Stage 2 peers: #1 of 3 in Business Support Services · #2 of 89 in Industrials
Is INDGN early, or has it already run? Pro answers that for every NSE stock, after every close.
INDGN among Business Support Services4th of 23 by relative strength
All 23 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | KAPSTON | Stage 3 · wk 2 | 98 | +2.1% |
| 2 | BLUSPRING | Stage 2 · wk 23 | 96 | +2.0% |
| 3 | ARTEMISMED | Stage 3 · wk 3 | 83 | +12.8% |
| 4 | INDGN | Stage 2 · wk 14 | 83 | +13.3% |
| 5 | KRYSTAL | Stage 3 · wk 3 | 73 | −4.3% |
| 6 | SIS | Stage 3 · wk 8 | 73 | −5.4% |
| 7 | UDS | Stage 3 · wk 2 | 72 | +0.7% |
| 8 | SANGHVIMOV | Stage 3 · wk 7 | 67 | +9.6% |
Mutual fund holdings
Held by 37 mutual funds in portfolios to October 2026: 29 active funds and 8 index funds and ETFs.
In October, among active funds: 1 increased, 9 reduced and 1 exited.
All 37 funds, the 1 that exited, and what each did in October
Mutual funds holding INDGN: the ten largest and the month’s moves →
Indegene: quick answers
What stage is Indegene in?
As of 20 Nov 2026, Indegene (INDGN) is in Stage 2, the uptrend phase. It entered Stage 2 on 13 Aug 2026 and is in week 14. What the four stages mean
Is Indegene in an uptrend?
Yes. Indegene is in a Stage 2 uptrend. It trades 23.5% above its 200-day average, which is rising.
How far is Indegene from its 52-week high?
Indegene closed at ₹658 on 20 Nov 2026, 1.3% below its 52-week high of ₹666. Its 52-week low is ₹424.
How has Indegene performed over the past year?
As of 20 Nov 2026, Indegene is up 27.9% over the past year and up 26.4% so far in 2026.
Which sector and industry is Indegene in?
Indegene is in the Business Support Services industry, part of the Industrials sector. 89 stocks in Industrials are in Stage 2, 16.6% of the sector. See the Stage 2 stocks in Industrials
About this companyIndustrials· Business Support Services
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.
Visit company website →All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.